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A B S T R A C T
In 1910, Darier and Civatte described in details an unusual melanocytic tumor characterized by rapid growth on the
nose of a young child. They could not state whether the tumor was benign or malignant. In 1947, Sophie Spitz described
the same lesion as juvenile melanoma in which prognosis was frequently excellent. Later, the study was revised and it
was concluded that juvenile melanoma was a benign tumor and can affect adults. Although, the prognosis was mostly
excellent, Spitz reported in one of 13 cases fatal metastases from nevus Spitz. In 1999, Barnhill et al described one fatal
case of the patient for whom it was thought to have typical Spitz nevus. Nowadays, there is still a lack of consensus about
histopathology and also a terminology of the tumors that are neither typical nevus Spitz, neither malignant melanoma.
All histopathological, clinical and ancillary criteria must be weighed in the final interpretation of epitheloid/spindle cell
lesion. At the present, the final diagnosis remains pathohistological, with important emphasis given to clinical impres-
sion. Persistently changing lesion indicates malignancy potential of the lesion. Barnhill recommends that all Spitz tu-
mors are completely excised. Atypical tumors should be excised with wider margins up to 1 cm. Patient should be care-
fully monitored by regular examinations for recurrence and metastasis.
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Introduction
In 1910, Darier and Civatte1 described in details an
unusual melanocytic tumor characterized by rapid growth
on the nose of a young child. They could not state
whether the tumor was benign or malignant. In 1947,
Sophie Spitz2 described the same lesion as juvenile mela-
noma in which prognosis was frequently excellent. Later,
the study was revised and it was concluded that juvenile
melanoma was a benign tumor and can affect adults3. Al-
though, the prognosis was mostly excellent, Spitz re-
ported in one of 13 cases fatal metastases from nevus
Spitz. In 1999, Barnhill et al.4 described one fatal case of
the patient for whom it was thought to have typical Spitz
nevus. Nowadays, there is still a lack of consensus about
histopathology and also a terminology of the tumors that
are neither typical nevus Spitz, neither malignant mela-
noma. The treatment of nevus Spitz is clear, but the sur-
gical margins of the tumor remain unclear. Gelbard5 in-
vestigated how American dermatologist and pediatrician
manage nevus Spitz. The majority of dermatologist and
pediatricians recommended 1–2 mm margin of normal
appearing skin around the nevus. They were also less
likely to monitor patients whose Spitz nevi were com-
pletely excised. 74% of respondents believed that nevus
Spitz was entirely benign lesions, 4% believed that it was
precursor of malignant melanoma, and 22% of the inter-
viewed physicians were not sure.
Typical Nevus Spitz
The prevalence of nevus Spitz (NS) is unknown in
general population, but they appear less often than ac-
quired and congenital melanocytic nevi6. The incidence
of NS in general population is about less than 0.2% and
in children about 1%. There is no sex prevalence and the
majority of nevi occur in children (about 60% by the age
of 30). The majority of NS occur on the head and neck
(37%), followed by 28% on lower extremities, 19% on the
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upper extremities and 6% on the trunk. NS is usually sol-
itary papule, but could also be multiple, widespread,
grouped, agminated or eruptive and usually less than 1
cm in diameter. The color is usually pink to red but could
range from flesh colored to tan, dark brown and black de-
pending on amount of melanin present and the vascula-
rity of the lesion7.
There are four clinical types of NS:
1. the light colored soft form which is pink to light
tan, smooth, and flatters with dermatoscopy,
2. the light colored hard form, which appears like a
dermatofibroma or keloid and may have halo and
teleangiectases,
3. the dark form, which is variably pigmented and
smooth,
4. the multiple form, which includes the grouped and
widespread, disseminated, eruptive lesions8.
Clinical differential diagnosis includes acquired me-
lanocytic nevus, dysplastic melanocytic nevus, congenital
melanocytic nevus, blue nevus, pyogenic granuloma, der-
matofibroma, hemangioma, angiofibroma, scar, keloid,
fibroma, xanthogranuloma, verruca vulgaris, molluscum
contagiosum, epidermal nevus, histiocitoma, xanthoma,
anthropod bite reaction, lichen planus, lupus vulgaris,
granuloma faciale, eosinophilic granuloma, pseudolym-
phoma, seborrheic keratosis, chondrodermatitis, nodular
helicis, actinic keratosis, pale cell achantoma, granular
cell tumor, leiomyoma, glomus tumor, squamous cell car-
cinoma, basal cell carcinoma, Kaposi sarcoma and angio-
sarcoma7.
The typical appearance under the dermatoscope is
pigmented spindle nevus with a striking starburst pat-
tern due to components that extend radially towards the
corona, leaving targetoid pattern (Figure 1a). The bran-
ched streaks reach the surrounding skin only occasion-
ally, usually dissipating before or in the corona and being
replaced by pigmented globules and dots9.
Although the bizarre histopathological features and
frequent occurrence of dermal inflammation may cause
diagnostic confusion, nevus Spitz when typical can be
differentiated from malignant melanoma10. Spitz nevi
are melanocytic nevi that are junctional (66%), com-
pound (11%) and dermal (18%). Melanocytic elements
are usually arranged in well-circumscribed nests in epi-
dermis and dermis. The epidermis is usually hyperpla-
stic, with elongated and bulbous pegs and knobs extend-
ing into the dermis (Figure 1b). Spindle cells preominate
in 45–54% of Spitz nevi, epitheloid cells in 21% and rela-
tively equal combination of cell types in 24–34%. The pig-
mented spindle cell nevus described by Reed et al.11 is
usually sharply demarcated, uniformly darkly pigmented
papule or plaque consisting of compact and aggregated
spindle-shaped, pigment-producing melanocytes, distin-
guished from melanoma by its uniform nuclei, uniform
cellular detail, and distinctive pattern of growth. Unlike
ordinary nevi and melanomas, melanocytic cells in Spitz
nevus are large, often twice the size of epidermal basal
keratinocytes (Figure 1c). Mitoses, usually few in num-
ber are nested in half the cases. The melanocytic cells in
NS show progressive maturation with increasing depth,
becoming smaller and more similar to ordinary melano-
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Fig. 1. a) Nevus Spitz under dermatoscope.
Fig. 1. b) Histological picture of typical nevus Spitz (100x HE).
Fig. 1. c) Histological picture of typical nevus Spitz (400x HE).
cytes. Coalescent oesinophilic globules (Kamino bodies),
PAS positive have been reported in 60% of Spitz nevi.
Similar globules might be found in melanomas, but in
only 2%.
Characteristics of conventional Spitz tumors from
Barnhill at al4:
Clinical features:
1. Configuration: papule or nodule, often dome-sha-
ped, or plaque,
2. Size: smaller than 1 cm,
3. Profile: often smooth surface,
4. Color: pink/red, pigment variants occur,
5. Age: major in children and adolescence, but also
any age,
6. Location: face and extremities,
7. Symptoms: commonly asymptomatic,




3. Sharp lateral demarcation,
4. Regular pattern of epidermal hyperplasia,
5. Zonation with depth:
a. Side to side uniformity, that is nests and fasci-
cles of melanocytes with fairly uniform size
and shape and regular spacing,
b. Diminished cellular density with depth,
c. Nests diminish in size and show transition to
single cells with depth,
d. Diminish non-disruptive infiltration of colla-
gen by melanocytes.
Cytological features:
1. Spindle and/or epitheloid cell type,
2. Overall monomorphous population of cells,
3. Low nuclear-to-cytoplasmatic ratio,
4. Opaque or ground-glass cytoplasm,
5. Nuclei with open, delicate chromatin patterns,
6. Uniform nucleoli,
7. Occasional striking pleomorphism in minority of
cells.
Other helpful diagnostic features:
1. Mitotic rate <2/mm2,
2. Absent or rare, but not atypical, mitoses in deep
parts,
3. Mononuclear and multinucleate giant cells,
4. Irregular contours of growth at deep margin,
5. Dull pink (Kamino) bodies- not pathogomonic fea-
ture,
6. Paucity or absence of single-cell upward spread (in
central part of lesion present),
7. Junctional clefts,
8. Loss of cohesion between cells (retraction spaces),
9. Perivascular or diffuse inflammatory infiltrate,
10.Superficial distribution of pigmentation,
11.Teleangiectasia and edema.
Concerning the treatment options, there is no doubt
that nevus Spitz should be completely excised with a
clear margin of normal skin is usually sufficient. For
histopathologically worrisome lesion, wider margin may
be prudent.
Da Forno et al.12 postulated a model according to the
model of nevus progression to dysplastic nevus and then
to melanoma (Table 1). Although, the model is not ac-
cepted by all, because the majority of melanoma rise
from de novo, this has led to speculation that similar pro-
cess occur in epitheloid cell tumors, whereby the NS be-
comes atypical NS and finally malignant melanoma. In
support to this, atypical NS show a spectrum of histolo-
gical features intermediate between classic NS and mela-
noma.
Atypical Nevus Spitz
The term atypical Spitz tumor was first used in the
English literature in 1975 by Reed et al.11, illustrating
NS that differed from classical NS. The difference was
that atypical tumor showed confluent and densely cellu-
lar fascicles of spindle cells that crowded and compressed
their stroma. Smith et al.13 described similar tumor as
spindle and epitheloid cell nevus with atypia and metas-
tasis. They were characterized by large size, more than 1
cm, with ulceration, deep extension into subcutaneous
fat with bulbous margins, prominent cellular density,
lack of maturation, cytological atypia, more than 2 mito-
sis and focal necrosis. These tumors developed in young
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TABLE 1
THE SPECTRUM OF HISTOLOGICAL FEATURES, DIAGNOSTIC TERMINOLOGY AND CLINICAL BEHAVIOR
OF NEVUS SPITZ AND OTHER EPITHELOID/SPITZOID CELL TUMORS BY DA FORNO ET AL
Histological features Classical Spitz nevus Malignat melanoma







Implied likely behavior Benign Probably benign Uncertain Malignant
STUMP – Spitz tumor of uncertain malignant potential
individuals and were located on the head and neck, and
extremities. Six patients had positive regional lymph
node metastases with involvement of the sinuses and pa-
renchyma by tumor identical to the primary cutaneous
lesion. The older the patients, especially beyond 20–30
years, the likelihood of malignancy are greater. The loca-
tion of atypical tumors on sites less commonly involved
by Spitz tumor, such as the back, is also another factor
suggesting careful follow up of the patient14. However,
there are some authors15 who disagree about the terms
»atypical« nevus Spitz »malignant« nevus Spitz, nevus
Spitz and metastasizing nevus Spitz. They found out
that an overwhelming majority of neoplasm that claimed
to be »atypical«, »metastasing« and »malignant« Spitz
nevi were in fact melanomas. Complementary to these
facts are the results of study of 12 patients with »atypi-
cal« nevus Spitz who underwent sentinel node biopsy.
Nodal micrometastases were found in 33.3% of patients16.
Histopatological criteria for atypical Spitz tumors from
Barnhill at al4:
1. Diameter in mm (³10 mm considered abnormal),




5. Pagetoid melanocytes over a larger front,
6. Prominent confluence of melanocytes,
7. Asymmetry,
8. Few or no dull pink (Kamino bodies),
9. High cellular densits,
10.Lack of zoonation and maturation.
Proliferation criteria from Barnhill at al4:
1. Significant mitotic rate ³2–6/mm2,
2. Deep/marginal mitoses
3. Proliferation index-Ki-67 expression between 2–10%;
³10%.
Cytological criteria from Barnhill at al4:
1. Granular vs. ground glass cytoplasm,
2. High nuclear to cytoplasmic ratios,
3. Loss or delicate or dispersed chromatin patterns,




Spitzoid melanoma term should be used for mela-
noma with morphological resemblance to nevus Spitz17.
The resemblance includes features: dome-shaped, pla-
que-like, wedge-shaped morphology, little or no asymme-
try, epidermal hyperplasia, clefting about intraepidermal
nests of melanocytes, presence of dull Kamino bodies,
some evidence of zonation or maturation and population
of enlarged epitheloid or/and spindelled melanocytes with
abundant opaque or glass cytoplasm18,19. The importance
of differentiation between NS and melanoma is empha-
sized in the literature. Recent data suggest that Spitz
nevi differ from melanomas in their immunohistochemi-
cal pattern of expression of cell cycle and apoptosis regu-
lators (bax, Ki-67, Rb, p-16, cyclin A, cyclin B1, p-27,
p-53) and more closely resemble common benign nevi20,21.
There are many authors who tried to find clear patho-
histological hallmarks of NS and Spitzoid melanoma.
Weedon D and Little JH22 find these features important;
presence of some nevus cells maturity at the base, an ab-
sence of atypical mitoses, no significant upward epider-
mal spread and the nuclear chromatin pattern. Crotty23
reviewed several studies and concluded that histological
features that support diagnosis of malignant melanoma
rather than atypical nevi are deep and marginal mitoses,
atypical mitoses, asymmetry, pleomorphisam and promi-
nent epidermal involvement. The same author compared
clinical and histopathological features of 13 malignant
melanomas in children under the age of 13 with 15 NS24.
Histological features favoring malignancy were mitoses
within 0.25 mm of the dermal margin of the melanoma, a
dermal mitotic rate exceeding 2/mm2, ulceration, sur-
face, exudates, large pigmented granules and clear-cell
differentiation. The median thickness of malignant mel-
anomas was 1.3 mm, but in 4 children, who died with
melanoma, median thickness was 2.9 mm. Absence of
mitoses, predominance of spindle cells and diffuse matu-
ration favored NS. The median thickness of the NS was
0.7 mm. The most frequent clinical features found in the
malignant melanoma were bleeding, ulceration, itching
and black or variegated color. Kapur et al.25 compared ex-
pression of Ki-67, p21 and fatty acids synthesis by immu-
nohistochemistry in 10 atypical NS, 28 typical NS, 19
compound melanocytic nevi and 18 malignant melano-
mas. There was a progressive increase in fatty acid syn-
thesis cytoplasmic expression with statistically signifi-
cant differences observed between Ns and atypical NS
and between atypical NS and malignant melanoma Ki-67
nuclear staining was lower in both typical and atypical
forms of Spitz lesions than in malignant melanoma. The
degree of p21 nuclear expression in atypical NS was not
significantly different than in NS, but was significantly
greater than expression in conventional nevi and ap-
proached significance after multiple comparisons correc-
tions for malignant melanoma. Thus, a high level of p21
expression makes a tumor more likely to be a typical or
atypical NS than a malignant melanoma, especially when
coupled with a low Ki-67 index and weak expression of
fatty acid synthase. These immunohistochemical obser-
vations support the concept that atypical NS are distinct
lesions of borderline biologic behavior residing between
NS and malignant melanoma. The study also compared a
large array of histological features of 16 cases of typical
NS in children with 12 typical NS in adults. The adult le-
sions were significantly more likely to be intradermal
and to display dermal fibroplasia, but were histologically
similar to their pediatric counterparts in all other re-
spects. Vollmer et al.26 in his study used previously pub-
lished data, exponential and g probability density func-
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tions to model statistical distributions of proliferation
index (PI), respectively, in NS and melanomas and Bayes
rule to estimate the predictive probability that a lesion is
a NS, given an observed PI. Results indicate that PIs
more than 10% favor a melanoma diagnosis and PIs less
than 2%, NS. PI values between 2% and 10% yield vari-
ous predictive values for NS, depending on the a priori
probability that the lesion is a NS.
Conclusion
All histopathological, clinical and ancillary criteria
must be weighed in the final interpretation of epithe-
loid/spindle cell lesion. At the present, the final diagnosis
remains pathohistological with important emphasis gi-
ven to clinical impression. Persistently changing lesion
indicates malignancy potential of the lesion. Barnhill
recommends that all Spitz tumors are completely ex-
cised. Atypical tumors should be excised with wider mar-
gins up to 1 cm. Patient should be carefully monitored by
regular examinations for recurrence and metastasis. The
approach should be individual with efforts to avoid over
treatment or suboptimal treatment. The need of proper
patient counseling cannot be overemphasized, especially
considering the psychological aspect of coping with ma-
lignant skin tumors27.
Protocol for Spitz tumor from Barnhill et al.4:
1. Examination of the entire lesion,
2. Application of all histopathological, clinical and ot-
her attributes for assessing abnormalities present,
3. Seek consultation,
4. Placement into risk category28 (Table 2),
5. Management of the patient.
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TABLE 2





























NEVUS SPITZ – PATOHISTOLO[KA DVOJBA
S A @ E T A K
1910. godine Darier i Civatte su detaljno opisali brzorastu}u, melanocitnu promjenu na vrhu nosa djeteta. Nisu sa
sigurno{}u mogli re}i jeli promjena benigne ili maligne naravi. 1947. godine Sophie Spitz je opisala identi~nu leziju kao
juvenilini melanoma sa relativno odli~nom prognozom. Kasnije je napravljena revizija studije te je zaklju~eno da se radi
o juvelnilnom melanomu koji je benigan, a mo`e se pojaviti ~ak i u odrasloj dobi. Iako je prognoza odli~na, Spitz je
opisala jedan slu~aj sa fatalnim metastazama. Barnhill i sur. su tako|er opisali smrtni ishod bolesnika za kojeg se
vjerovalo da ima Nevus Spitz. I u dana{nje vrijeme, tako|er postoji nesuglasje oko histopatologije i terminologije pro-
mjena koje nisu ni atipi~ni nevus Spitz, ali ni melanom. Kod dono{enje kona~ne odluke, trebaju se uzeti u obzir sva
histolo{ka i klini~ka obilje`ja promjena. Promjene koje se neprestano mijenjaju upu}uju na maligni potencijal. Barnhill
i sur. predla`u da se svi tipi~ni Spitz nevusi trebaju operativno odstraniti u cijelosti. Za atipi~ne promjene predla`e
rubove do 1 cm. Sve bolesnike treba redovito kontrolirati radi lokalnog recidiva i/ili metastaza.
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